Descriptive data recorded at time of Medical Outcome Study Short-Form 36 survey for 68 Danish patients with inactive Wegener’s granulomatosis (WG).
| Characteristic | |
|---|---|
| No. patients | 68 |
| Sex, no. (%) | |
| Male | 36 (53) |
| Female | 32 (47) |
| Median age, yrs (range) | 58 (17–78) |
| Median time since WG diagnosis, yrs (range) | 7.5 (1–26) |
| Immunosuppressive medication, % of patients | |
| Methotrexate +/– prednisolone therapy (≤ 10 mg/day) | 25.0 |
| Low-dose prednisolone monotherapy (≤ 10 mg/day) | 8.8 |
| Other drugs* +/– prednisolone therapy (≤ 10 mg/day) | 7.4 |
| No immunosuppressive medication | 58.8 |
| Median no. WG relapses (range) | 1.0 (0–3) |
| Median Vasculitis Damage Index score (range) | 2.0 (0–7) |
| Damage by organ system, % of patients | |
| Musculoskeletal | 5.9 |
| Skin/mucous membranes | 1.5 |
| Ocular | 13.2 |
| Ear, nose, throat | 36.8 |
| Pulmonary | 17.6 |
| Cardiovascular | 27.9 |
| Peripheral vascular disease | 14.7 |
| Gastrointestinal | 0.0 |
| Renal | 23.5 |
| Neuropsychiatric | 44.1 |
| Other | 10.3 |
| Median no. organ systems with damage** (range) | 2.0 (0–5) |